logo
mRNA Scaffold and Cancer Immuno-therapy: Biochemical and Clinical Aspects

Haseeba Shahzad1*, Saba Saeed2, Hajira Kalsoom1, Fizza Mubashir1, Zulqurnain Khan3*, Khunsa Tariq4, Iqra Azhar5, Ayesha Liaqat6, Faiza Farooq7, Huma Butt8

1School of Biochemistry and Biotechnology, University of the Punjab, Quaid-i-Azam Campus, Lahore 54590, Pakistan

2Institute of Biochemistry and Biotechnology, The University of Veterinary and Animal Sciences, Lahore, Pakistan

3Institute of Plant Breeding and Biotechnology (IPBB), MNS University of Agriculture, Multan 66000, Pakistan

4Institute of Biochemistry and Molecular Biology, Heinrich Heine University Düsseldorf, Germany

5Department of Biochemistry, Faculty of Biological sciences Quaid-i-Azam University, Islamabad 45320, Pakistan

6School of Biological Sciences, University of the Punjab, Quaid-i-Azam Campus, Lahore 54590, Pakistan

7College of Pharmacy, University of Manitoba, Canada

8Department of Pharmaceutics, The Islamia University of Bahawalpur, Pakistan

*For Correspondence

haseebashahzad388@gmail.com

zulqurnain.khan@mnsuam.edu.pk

Publication Date: October 19, 2023
DOI: 10.5281/zenodo.10250599
Read Abstract

Messenger RNA (mRNA) is in the spotlight as a striking tool for the intervention of various human disorders chiefly malignant tumors, now a days. Thanks to the excellent clinical consequences of mRNA vaccines. Recent propitious preclinical and clinical outcomes that typify the headway in mRNA and nanoformulation-based delivery scaffolds have illuminated the efficacious aptitude of mRNA in cancer immunotherapy. The mRNA can be used for cancer immunotherapy in the form of many therapeutic techniques like adoptive T-cell therapy, therapeutic antibodies, cancer vaccines and immunomodulatory proteins. This chapter highlights the comprehensive overview of the evolving role of mRNA technology against cancer, the underlying mode of action of various types of emerging mRNA-based cancer vaccines as well as immunomodulatory proteins, current status and anticipation of mRNA-based therapeutics inclusive of various delivery strategies as well as has opened new avenues to overcome the deficiencies.

Keywords

mRNA Technology, Cancer Immuno-therapy, Biochemical, Clinical Aspects, Recent Study

Download PDF